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Objective: To review all published reports and investigate the clinical relevance and need for treatment of carotid stent
fractures.
Methods: Electronic and hand-searching of the published literature and the Manufacturer and User Facility Device
Experience (MAUDE) database.
Results:Thirteen articles were published. There are 10 case reports and 3 clinical studies. There are 26 reports of fractured
stents in theMAUDE database. Fifty-five cases of carotid stent fractures are reported in total. A total of 201 carotid stents
were examined in the 3 studies, and the incidence of fractures was 8.9% (18/201). Fractured stents were 22 Xact, 20
Acculink, 6 Precise, 2 Exponent, 1 Nexstent, 1 Genesis, 1 Symbiot, and 2 nonspecified nitinol self-expandable stents.
Twenty-seven of the treated carotid lesions were atherosclerotic, 3 restenoses after carotid endarterectomy, 2 postradia-
tional, 1 pseudoaneurysm, and 22 lesions of unknown pathology. Calcification was reported in 15 of the 27 atheroscle-
rotic lesions (55.5%). Time from implantation to fracture ranged from 0 days (fracture during implantation) to 37
months. In 55% of the cases, stent fracture was associated with restenosis. Six patients presented with symptoms.
Treatment was reported for 32 patients: 14 patients underwent de novo stent placement, 2 balloon angioplasty, 2 carotid
endarterectomy, 2 bypass graft (1 vein, 1 polytetrafluoroethylene), 1 anticoagulation, and 11 patients were followed up.
Conclusion:Carotid stent fractures are mainly reported in self-expandable nitinol stents. Plaque calcification may be a risk
factor for stent fractures. No difference was observed between open and closed-cell design. Stent fractures were often
associated with restenosis and usually were asymptomatic. The actual incidence, clinical relevance, and optimal treatment
remain to be clarified from larger prospective studies designed to investigate the issue. (J Vasc Surg 2010;51:1280-5.)Carotid artery stent (CAS) placement with embolic
protection is an alternative treatment for patients with
internal carotid artery stenosis who are at high risk for
carotid endarterectomy. Most of the studies reporting on
the long terms of CAS focus on clinical outcomes and
restenosis rate. However, detailed information of the be-
havior of stents in the carotid artery is still lacking. The
Food and Drug Administration (FDA) has long been con-
cerned with the durability of stents. As the use of CAS
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1280expands and the number of reported incidences of compli-
cations related to this procedure grows, it seems necessary
to assess the incidence and clinical implications of stent
fractures after CAS. The aim of this study is to review all
published reports and investigate the clinical relevance and
need for treatment of carotid stent fractures.
METHODS
An electronic search of the published literature in
PubMed from 1990 up to December 2009 was conducted.
The terms used for this were stent fracture, stent breakage,
carotid, stenosis. Further hand-searching of the relevant
references of those articles retrieved from electronic
searches was made. The Manufacturer and User Facility
Device Experience (MAUDE) database was also searched
(http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/
cfMAUDE/search.CFM). The terms used were fracture
and break for product problem and carotid stent for
product class. Date reports received by FDA: 01/01/
1997 to 12/29/2009. The obtained reports (67 in
total) were reviewed, and those describing carotid stent
fractures were included in the analysis. The reports that
acility
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fracture of other parts of the device were excluded.
Carotid stent fractures were classified according to the
Nitinol stent fracture classification proposed by the Cardio-
vascular Institute of the South (CIS) for Nitinol stent
fracture standardization.1 Type I fractures involve a single
strut fracture only, type II fractures involvemultiple Nitinol
stent fractures that can occur at different sites, type III
fractures involve multiple Nitinol stent fractures resulting
in a complete transverse linear fracture but without stent
displacement, and type IV fractures have a complete trans-
verse linear fracture with stent displacement.
RESULTS
Thirteen articles were published. There are 10 case
reports and 3 clinical studies. There are 26 reports of
fractured stents in the MAUDE database. Fifty-five cases of
carotid stent fractures are reported in total. Twenty-seven
of the treated carotid lesions were atherosclerotic, 3 reste-
noses after carotid endarterectomy, 2 postradiational, 1
pseudoaneurysm, and 22 lesions of unknown pathology.
Calcification was reported in 15 of the 27 atherosclerotic
lesions (55.5%). All but one (Genesis; Johnson & Johnson,
New Brunswick, NJ) were related to self-expandable stents.
Fractured self-expandable stents included 22 Xact (Abbott
Laboratories, Abbott Park, Ill), 20 Acculink (Abbott Lab-
oratories), 6 Precise (Cordis, Miami Lakes, Fla), 2 Expo-
nent (Medtronic Vascular, Santa Rosa, Calif), 1 Nexstent
(Boston Scientific, Natick, Mass), 1 Symbiot self-expand-
ing covered stent (Boston Scientific), and 2 nonspecified
nitinol self-expandable stents. Twenty-three of the 52 spec-
ified fractured self-expandable stents (44%) had closed-cell
Table. Reported cases of carotid stent fracture
Author N Carotid st
Valibhoy2 1 Atherosclerotic
Surdell3 1 Atherosclerotic
Ling4 14 Atherosclerotic
Diehm5 1 Atherosclerotic
Nazzal6 1 Atherosclerotic
Varcoe7 1 Atherosclerotic
Habib8 1 Atherosclerotic
Boehm9 2 Atherosclerotic, postr
Ross10 1 Postradiation
Abullage11 1 Restenosis
Saad12 1 Restenosis
deVries13 1 Pseudoaneurysm
Chang 14 3 Nr
MAUDE Database 26 Atherosclerotic (6)
Restenosis (1)
BE, Balloon expandable; CAS, carotid stenting; CE, carotid endarterecto
angiography; DUS, duplex ultrasound; MAUDE, Manufacturer and User F
reported; SE, self-expandable.design. There are 6 type I, 11 type II, 9 type III, and 6 typeIV fractures; the rest are not described. Time from implan-
tation to fracture ranged from 0 days (fracture during
implantation) to 37 months. There are six reported cases of
fracture during implantation, all associated with Acculink
stents. In 55% of the cases (25/45), stent fracture was
associated with restenosis. Six patients presented with
symptoms. Two presented with contralateral stroke, two
with neck hematoma, one had drop attacks during head
movement, and in one patient, symptoms were not de-
scribed. In a case of stent fracture during implantation, the
filter embolic protection device was captured by broken
stent struts during retrieval. Treatment was reported for 32
patients: 14 patients underwent de novo stent placement, 2
balloon angioplasty, 2 carotid endarterectomy, 2 bypass
graft (1 vein, 1 polytetrafluoroethylene), 1 anticoagulation,
and 11 patients were followed up (Table).
Three clinical studies reported on the incidence of
carotid stent fractures presenting conflicting results: Ling et
al performed a retrospective study of patients from one
surgeon’s private practice. They reported an incidence of
stent fractures of 29.2% (14 of the 48 stents examined). The
presence of calcified vessels was significantly associated with
the presence of fractures. Fractures occurred 7.7 times
more frequently in calcified lesions.4 Varcoe et al reported
an incidence of 1.9% of carotid stent fractures (1 of the 53
stents examined). It was a type I fracture. They also noted
that another six stents had an irregular tiled appearance,
similar to fish scales, that can be confused for stent frac-
ture.7 Chang et al evaluated 100 stents with neck films;
there were 50 closed-cell stents and 50 open-cell stents.
They found three stent fractures that occurred in closed-
cell Xact stents placed 1 year prior to examination (3 of
Calcification Stent type
— Xact
— Nitinol
8 Xact (8)
Precise (4)
Exponent (2)
— Xact
— Acculink
1 Precise
1 Acculink
ion (CCA) — Nextstent, Genesis
Xact
Xact
Nitinol
Symbiot
2 Xact (3)
5/6 Acculink (18)
Xact (7)
Precise (1)
TA, computerized tomographic angiography; DSA, digital substraction
Device Experience; PTA, percutaneous transluminal angioplasty; Nr, notenosis
adiat
my; C100 or 3% overall incidence, 12% for Xact stents). No other
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associated with the presence of calcified plaque noted on
plain films.14 A total of 201 stents were examined in these 3
studies, and 18 of them were reported fractured (8.9%).
DISCUSSION
Stent fractures have been described in the aorta; the
vertebral, coronary, renal, pulmonary, femoral, popliteal,
and tibial arteries, the biliary tract; hemodialysis fistulas;
and coronary saphenous vein grafts.15-25 Fractures in the
femoropopliteal segment are associated with high resteno-
sis rates and reduced patency.21 Stent fracture has been
reported to occur in areas with flexible arteries and in those
with repetitive movements, such as the knee area. Carotid
artery is lately recognized as a potential site of stent fracture
because of the rotation and flexion forces.
Factors contributing to stent fracture include external
mechanical forces such as arterial shortening, axial rigidity,
kinking, and compression.26 Implantation of a carotid stent
was shown to be associated with a substantial reduction of
arterial compliance of the extracranial arteries. Pulsatile
blood flow through the stent can transmit extensive inter-
nal stress, contributing to stent fracture, especially near the
heart or great vessels.27 However, in vitro examination of
nitinol stents concluded that strains imposed by pulsatile
motion are not sufficiently high to cause fatigue, and are
therefore not principally responsible for stent fractures ob-
served in the superficial femoral artery.28 The length of the
stented segment has also been proposed as a factor in stent
fracture. The longer the stented segment and the more
overlapping stents are used, the more liable the stents are to
Table. Continued.
Time to fracture (months) Diagnosis
6 DSA
6 DSA
4 to 37 (mean, 18) Plain radiography, DUS
12 DUS
12 days DSA
23 Multiplanar radiography, selective D
0 Intraoperative DSA
4
17
CTA
CTA
5 DUS
7 CTA
3 CTA
7 CT
12 Multiplanar radiography
0-24 (mean, 9) DSA (9)
Intraoperative DSA (6)
Plain radiography (2)fracture.21The carotid bifurcation is located in a highly mobile
part of human anatomy, such as the femoropopliteal seg-
ment. The neck may rotate around the central axis of the
cervical spine and perform flexion and extension over the
length of cervical vertebrae. Head and neck movements
expose a carotid stent to forces of axial and crush deforma-
tion.29 Vos et al determined the effect of head movement
on in situ carotid stents using three-dimensional time-of-
flight magnetic resonance angiography. They found that
carotid artery loses its natural flexion and extension and
rotational flexibility following CAS.30 Furthermore, the ex
vivo flexibility properties of the stents themselves are lost
when placed in vivo. Therefore, the stented segment of the
artery appears as a stiff, inflexible unit in all head positions.
The unstented segments of the vessel are left to accommo-
date head movements, resulting in sharp angulations of up
to 85 degrees at the junctions between the stent and
artery.30 The carotid artery is only partially able to accom-
modate the changes in geometry that result from physio-
logic movements of the head, which may lead to kinking at
the distal end of the stent. Also, they found that the
common carotid artery and the internal carotid artery are
subjected to considerable torsion shear with head turn-
ing. These vessels present a physiological tendency to
twist around each other, because of the differences in
outflow resistance between the internal and external
carotid arteries, creating a further torque and shear force.
All of these shear forces lead to friction at both ends of
the stent, place ongoing stress on the stent, and can
possibly be a contributing cause to fracture.30 Addition-
ally, elastic recoil owing to pharyngeal muscle contrac-
Type of fracture Restenosis Symptoms Treatment
III   CE
III  Nr CAS
I:3
II:6
III:2
IV:2
3/14 Nr Nr
III   None
II   Anticoagulation
I   None
II   None
IV
III




CAS
CAS
III   CE
IV   CAS
IV   None
—   PTFE graft
Nr Nr Nr Nr
I (2)
II (3)
III (2)
IV (1)
13/20 4/20 CAS (10)
PTA (2)
Vein graft (1)
None (7)UStion and external musculoskeletal compression are added
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the carotid artery.6 Swallowing results in a medial crush
of the stented artery due to contraction of the pharyngeal
constrictor muscles.29
Heavy calcification of the carotid artery has been re-
ported as an important predictor of complications follow-
ing carotid artery stenting. The calcification impedes com-
plete expansion of the stent. This can lead to an acute
fracture of the stent, sometimes responsible for in-stent
restenosis.4,31 The presence of calcification exerts an exter-
nal loading force on the stent. Because of the irregularity of
calcified plaques, focal pressure is placed on certain parts of
a stent in situ, and this could be exacerbated by neck
movements. A calcified vessel also creates a more rigid
artery and a point of fixation on the stent in situ, necessi-
tating that the proximal and distal unstented segments of
artery accommodate in-neck movement. This creates re-
gional friction, increasing the risk of fracture.4 Plaque cal-
cification is reported in 55.5% of the atherosclerotic cases
with stent fractures.
Fatigue and fracture of stents originate at stress concen-
tration regions that are under alternating external loading
modes (pressure, bending moments, and torsion mo-
ments). The external loading produces tensile background
stresses, which accumulate material defects.32 The micro-
scopic defects, after many load cycles, produce microcracks,
which enlarge to macrocracks under favorable environmen-
tal and stress conditions. The rate of microcrack enlarge-
ment depends mainly on the material of which the stent is
made. Once a crack has reached a critical size, there can be
an abrupt final fracture that severs the structural continuity
of the stent.33
From the structural point of view, the stent is a cylin-
drical shell. Calcification plaques form on this shell and can
cause severe stress concentrations at locations where the
plaques end. The plaques have a different (typically higher)
elastic modulus from the stent. Such elastic mismatch leads
to stress concentrations. Pulsative internal blood pressure,
but also bending and torsion, can cause very high tensile
stresses in the vicinity of the plaque-stent boundary.34
Fatigue cracks can initiate, enlarge, and finally become
critical after a sufficient number of pulses.
Stents with closed-cell design have overlapping or
fully connecting struts, as compared with stents with
open-cell design, which have both connecting and non-
connecting struts. The former have higher surface cov-
erage, but there are no studies demonstrating a differ-
ence in fracture rates between the two designs in other
arterial beds. In carotid arteries, similarly, there is no
difference in fracture rates.
Detecting stent fractures may be more challenging
than anticipated. Stent fractures may not be adequately
detected with the unmagnified anteroposterior and lat-
eral radiographic views. Plain radiographic images have
an uncertain sensitivity and specificity even at magnified
levels.4 Scrutinizing the fine struts of these small stents
requires magnification and removal of interference from
overlying bony structures.7 Open-cell stents may presentan irregular tiled appearance similar to fish scales that can
be easily confused for stent fracture.7 Doppler ultra-
sound is the common examination performed in the
follow-up after CAS, but it is an indirect imaging method
measuring flow rates, and there is no possibility to di-
rectly visualize the stent. Stent fractures cannot be iden-
tified by ultrasound.9 In patients with suspected resteno-
sis by ultrasound, it is recommended to use computed
tomography angiography to evaluate the stents’ lumen
and depict the reason for the restenosis.9 Rotational
angiography without contrast can identify carotid stent
fractures because it provides the possibility to magnify
and to remove the interference of bony structures by
changing the viewing angle. A proposed algorithm for
the detection of carotid stent fractures could be the
following: intraoperatively, during completion angiogra-
phy, a magnified picture of the stent should always be
obtained, and it should be carefully inspected for strut
fractures, especially in heavily calcified lesions. This pic-
ture will be used as a future reference image. In the
postoperative follow-up, in addition to duplex ultra-
sound, unmagnified anteroposterior and lateral radio-
graphic views should be performed at 12 months and
yearly thereafter. Patients with ultrasonographically-de-
tected restenosis and patients with suspected stent frac-
ture in the plain radiography should be subjected to
rotational angiography without contrast.
There is a striking disparity in carotid stent fracture
rates between the three published clinical studies. The
group from Dartmouth reported a 3% total incidence of
stent fractures, with all fractures occurring to Xact
stents.14 The group from Westmead, Sydney reported an
incidence of 1.9%,7 with a single fracture that occurred in
a Precise stent. Contrarily, the group from Perth re-
ported a remarkably higher incidence of 29.2%; 14 frac-
tures occurring in 8 Xact, 4 Precise, and 2 Exponent
stents.4 This disparity is difficult to explain. Plaque cal-
cification could be a factor affecting the reported inci-
dence of fractures. The study from Perth provides ade-
quate data regarding plaque calcification: 8 out of the 14
fractured stents were associated with local calcification in
the region of the deployed stent, whereas 5 out of the 34
stents without a fracture had localized calcification. The
presence of calcification resulted in a 7.7-times greater
odds for a fractured stent.4 The study from Dartmouth
reports that two of the three stent fractures were associ-
ated with the presence of calcified plaque noted on plain
films but does not provide any data about the total
number of patients with calcification.14 The study from
Sydney does not provide any data about plaque charac-
teristics. Moreover, 21% of the patients had radiation-
induced stenosis and postendarterectomy restenosis,
considered uncalcified lesions.7 It is possible that the
latter two studies included a smaller number of patients
with significant plaque calcification; consequently, the
number of stent fractures was decreased. Another factor
that could affect the results is the type of stent used. The
JOURNAL OF VASCULAR SURGERY
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were not used in the study from Sydney.
The clinical relevance of carotid stent fractures in
association with restenosis and stroke has not been clar-
ified yet. In this review, we found that 55% of the
reported fractures that provided adequate data (25/45)
were associated with restenosis. However, in most cases,
restenosis was initially found and, during further inves-
tigation, stent fracture was discovered. We do not exactly
know what percentage of carotid stent fractures lead to
restenosis. Ling et al reported that, although this series
of carotid arterial stent fractures had a fracture rate of
30%, the majority were benign at the time of this writing;
only 3 of these had restenosis 50% on surveillance
ultrasound scans at an average of 12 months postimplan-
tation. Type IV fractures, which by definition are dis-
placed, did not have restenosis detected.4 However, not
all fractures are benign and can progress to a clinically
significant stenosis. Furthermore, we do not know how
many of the restenoses produce symptoms. In our re-
view, we found six patients that presented with symp-
toms, and only two of them had suffered an ipsilateral
ischemic stroke.
To date, there is limited information regarding opti-
mal management of carotid stent fractures. In asymp-
tomatic patients without restenosis, follow-up seems to
be a reasonable treatment. Eleven of the 32 patients with
available data regarding treatment were followed up.
When fracture is complicated with thrombus formation,
anticoagulation is needed. In this case, restenting should
be avoided because it might be associated with signifi-
cant risk of distal embolization. The presence of neuro-
logic symptoms or in case of severe in-stent restenosis,
restenting of the lesion can be performed by a bridging
nitinol self-expanding stent. This is an acceptable ap-
proach for long-term restenosis rather than early stent
fracture with thrombus formation.6 However, the inser-
tion of another stent would further stiffen the carotid
segment, increasing the susceptibility to further stent
fractures. De novo carotid stenting was the procedure
most often performed in these patients. Fourteen of the
32 underwent carotid stenting, and 2 underwent balloon
angioplasty. In the presence of impedance to the blood
flow, neurologic deficit, stent penetrating the carotid
wall, or dissection of the carotid artery, open surgery
with stent removal is an alternative option.6 Successful
endarterectomy was reported in two cases after carotid
stent fracture.2,10 Two cases of bypass graft using vein
and polytetrafluoroethylene have also been described.13
After consideration of the potential for stent fractures
in patients that underwent CAS and the uncertainty regard-
ing its incidence, clinical outcome, and treatment, it is
necessary to investigate the issue in large prospective stud-
ies in patients treated only for atherosclerotic disease, tak-
ing into account the plaque type, the specific type of stent,
and the carotid anatomy using specific radiographic and
ultrasonic assessment.AUTHOR CONTRIBUTIONS
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